Biodesix, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for BDSX, updated each market day.
BDSX AI Sentiment
AI predicts Biodesix, Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Biodesix, Inc. Common Stock
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
Sector
Exchange
Market Cap
$131,313,328
Cap Tier
Employees
334
Headquarters
LOUISVILLE, CO
Listed Since
Oct. 28, 2020
Website
BDSX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
BDSX Volatility
Biodesix, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
